MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
38.53
-1.21 (-3.04%)
At close: May 09, 2025, 3:59 PM
38.47
-0.16%
After-hours: May 09, 2025, 04:05 PM EDT
-3.04% (1D)
| Bid | 36 |
| Market Cap | 2.45B |
| Revenue (ttm) | 101.85K |
| Net Income (ttm) | -118.94M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -20.39 |
| Forward PE | -10.41 |
| Analyst | Buy |
| Ask | 42 |
| Volume | 215,703 |
| Avg. Volume (20D) | 429,131 |
| Open | 39.74 |
| Previous Close | 39.74 |
| Day's Range | 38.13 - 40.65 |
| 52-Week Range | 31.42 - 58.26 |
| Beta | 1.30 |
About MLTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MLTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+2.53%
MoonLake Immunotherapeutics shares are trading hig...
Unlock content with
Pro Subscription
3 months ago
+5.64%
MoonLake Immunotherapeutics shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $62 to $82.
